Lv753
3710 积分 2022-08-26 加入
Treatment of Richter transformation—immunotherapy to the rescue?
3小时前
求助中
Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton’s Tyrosine KinaseClic
1天前
待确认
Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase
1天前
待确认
A multiprotein supercomplex controlling oncogenic signalling in lymphoma
8天前
已完结
Retrospective analysis of treatment patterns and outcomes in older adults with diffuse large B-cell lymphoma in the Veterans Health Administration
11天前
已完结
New BTK Inhibitors May Combat Resistance in CLL
11天前
已完结
BTK inhibitors resistance in B cell malignancies: Mechanisms and potential therapeutic strategies
13天前
已完结
Retrospective analysis of treatment patterns and outcomes in older adults with diffuse large B-cell lymphoma in the Veterans Health Administration
14天前
已完结
Meta‐analysis evaluating the efficacy and safety of various Bruton tyrosine kinase (BTK) inhibitors for central nervous system lymphoma: Novel covalent BTK inhibitors, except for ibrutinib, also demonstrate good efficacy in the treatment of primary central nervous system lymphoma
15天前
已完结
皖公网安备34019202002308
